{
    "Trade/Device Name(s)": [
        "Xpert GBS LB XC",
        "GeneXpert Dx System",
        "GeneXpert Infinity System"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K203429",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121539"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NJR",
        "OOI"
    ],
    "Summary Letter Date": "November 18, 2020",
    "Summary Letter Received Date": "November 20, 2020",
    "Submission Date": "December 06, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3740",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Streptococcus Spp. Serological Reagents",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Group B Streptococcus (Streptococcus agalactiae) DNA"
    ],
    "Specimen Type(s)": [
        "Enriched Lim broth cultures from vaginal/rectal swabs"
    ],
    "Specimen Container(s)": [
        "Cepheid Swab Collection Device",
        "Equivalent swab in non-nutritive transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System",
        "GeneXpert Infinity System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time polymerase chain reaction (PCR)",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "Qualitative PCR",
        "Automated sample preparation and detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert GBS LB XC test, a qualitative automated PCR assay for detection of Group B Streptococcus DNA from enriched vaginal/rectal swab specimens using the GeneXpert platform.",
    "Indications for Use Summary": "Automated qualitative in vitro diagnostic test to detect Group B Streptococcus DNA from enriched vaginal/rectal swab specimens, aiding in determining GBS colonization status of antepartum women.",
    "fda_folder": "Microbiology"
}